In 2018, the S&P 500 lost 6.2%, the NASDAQ Composite shrank 3.9%, and the TSX pared 12.2%. These were spectacular returns when compared to the 34.5% decline suffered by the TSX Venture! But not all TSX Venture companies swirled the bowl. In fact, several companies outperformed all of the broader indices.

Sophic Capital is bringing the #1 and #2 best performing companies on the TSX Venture tech index (respective returns of 114% and 96% in 2018) to the 2019 Cantech Investment Conference in Toronto on January 29 through 30. Plus, we’re bringing an innovative private company about to go public in February – a machine learning / predictive analytics data asset play for medical marijuana. Please contact us if you are interested in meeting management in a one-on-one or drop by the companies’ booths for an update.

Here are some brief company bios:

Kraken Robotics (PNG:TSXV) – 114% return in 2018
  • Leader in underwater robotics, batteries, and sensors for military and commercial markets
  • $200M+ active business pursuits that should be awarded 12-18 months
  • Insiders own ~30% of Kraken
  • CFO Greg Reid will present Kraken’s investment thesis at 11:50am EST, Tuesday, January 29 at the Paradigm Innovation Stage
  • Booth #301

OneSoft Solutions (OSS:TSXV) – 96% return in 2018

  • Machine learning software for predicting oil and natural gas pipeline failures
  • Insiders own 38% of OneSoft
  • CEO Dwayne Kushniruk will present OneSoft’s investment thesis at 11:45am EST, Tuesday, January 29 at the TSX Stage
  • Booth #502


CB2 Insights (Private, but expected to go public in February 2019 CBII:CSE)
  • Predictive analytics engine that is quickly building the industry’s largest data asset in medical cannabis-related real-world evidence
  • Accretively acquiring U.S. clinics, while streamlining and standardizing patient data into a central hub that currently holds cannabis-related treatments and outcomes on 65,000 patient across 28 clinics in 12 U.S. states
  • Raised more than $4.5 million recently – lead investor is Merida Capital (one of the largest U.S. VC’s in the cannabis industry with over $75mm deployed –
  • CB2 Insights does not touch the plant
  • Insiders own ~30% of CB2
  • Mr. Sekar will present CB2’s investment thesis at 3:10pm EST, Wednesday, January 30 at the TSX Stage
  • Cantech has also invited Mr. Sekar to be a guest on the Cannabis & Big Data panel at 10:30am EST, Tuesday, January 29 at the Paradigm Innovation Stage
  • Booth #500